Your browser doesn't support javascript.
loading
Combination of light-driven co-delivery of chemodrugs and plasmonic-induced heat for cancer therapeutics using hybrid protein nanocapsules.
Villar-Alvarez, E; Cambón, A; Pardo, A; Arellano, L; Marcos, A V; Pelaz, B; Del Pino, P; Bouzas Mosquera, A; Mosquera, V X; Almodlej, A; Prieto, G; Barbosa, S; Taboada, P.
  • Villar-Alvarez E; Grupo de Física de Coloides y Polímeros, Departamento de Física de la Materia Condensada, Universidad de Santiago de Compostela, 15782, Santiago de Compostela, Spain. eva.mailbox1@ugmail.com.
  • Cambón A; Grupo de Física de Coloides y Polímeros, Departamento de Física de la Materia Condensada, Universidad de Santiago de Compostela, 15782, Santiago de Compostela, Spain.
  • Pardo A; Grupo de Física de Coloides y Polímeros, Departamento de Física de la Materia Condensada, Universidad de Santiago de Compostela, 15782, Santiago de Compostela, Spain.
  • Arellano L; Grupo de Física de Coloides y Polímeros, Departamento de Física de la Materia Condensada, Universidad de Santiago de Compostela, 15782, Santiago de Compostela, Spain.
  • Marcos AV; Grupo de Física de Coloides y Polímeros, Departamento de Física de la Materia Condensada, Universidad de Santiago de Compostela, 15782, Santiago de Compostela, Spain.
  • Pelaz B; Grupo de Física de Coloides y Polímeros, Departamento de Física de la Materia Condensada, Universidad de Santiago de Compostela, 15782, Santiago de Compostela, Spain.
  • Del Pino P; Centro Singular de Investigación en Química Biológica y Materiales Moleculares (CiQUS), Universidad de Santiago de Compostela, 15782, Santiago de Compostela, Spain.
  • Bouzas Mosquera A; Grupo de Física de Coloides y Polímeros, Departamento de Física de la Materia Condensada, Universidad de Santiago de Compostela, 15782, Santiago de Compostela, Spain.
  • Mosquera VX; Centro Singular de Investigación en Química Biológica y Materiales Moleculares (CiQUS), Universidad de Santiago de Compostela, 15782, Santiago de Compostela, Spain.
  • Almodlej A; Departamento de Cirugía Cardíaca, Complexo Hospitalario Universitario A Coruña, Instituto de Investigación Biomédica de A Coruña (INIBIC), A Coruña, Spain.
  • Prieto G; Departamento de Cirugía Cardíaca, Complexo Hospitalario Universitario A Coruña, Instituto de Investigación Biomédica de A Coruña (INIBIC), A Coruña, Spain.
  • Barbosa S; Department of Physics and Astronomy, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia.
  • Taboada P; Grupo de Biofísica e Interfases, Departamento de Física Aplicada, Universidad de Santiago de Compostela, 15782, Santiago de Compostela, Spain.
J Nanobiotechnology ; 17(1): 106, 2019 Oct 15.
Article en En | MEDLINE | ID: mdl-31615570
ABSTRACT

BACKGROUND:

Improving the water solubility of hydrophobic drugs, increasing their accumulation in tumor tissue and allowing their simultaneous action by different pathways are essential issues for a successful chemotherapeutic activity in cancer treatment. Considering potential clinical application in the future, it will be promising to achieve such purposes by developing new biocompatible hybrid nanocarriers with multimodal therapeutic activity.

RESULTS:

We designed and characterised a hybrid nanocarrier based on human serum albumin/chitosan nanoparticles (HSA/chitosan NPs) able to encapsulate free docetaxel (DTX) and doxorubicin-modified gold nanorods (DOXO-GNRs) to simultaneously exploit the complementary chemotherapeutic activities of both antineoplasic compounds together with the plasmonic optical properties of the embedded GNRs for plasmonic-based photothermal therapy (PPTT). DOXO was assembled onto GNR surfaces following a layer-by-layer (LbL) coating strategy, which allowed to partially control its release quasi-independently release regarding DTX under the use of near infrared (NIR)-light laser stimulation of GNRs. In vitro cytotoxicity experiments using triple negative breast MDA-MB-231 cancer cells showed that the developed dual drug encapsulation approach produces a strong synergistic toxic effect to tumoral cells compared to the administration of the combined free drugs; additionally, PPTT enhances the cytostatic efficacy allowing cell toxicities close to 90% after a single low irradiation dose and keeping apoptosis as the main cell death mechanism.

CONCLUSIONS:

This work demonstrates that by means of a rational design, a single hybrid nanoconstruct can simultaneously supply complementary therapeutic strategies to treat tumors and, in particular, metastatic breast cancers with good results making use of its stimuli-responsiveness as well as its inherent physico-chemical properties.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Doxorrubicina / Nanocápsulas / Neoplasias de la Mama Triple Negativas / Albúmina Sérica Humana / Docetaxel / Antineoplásicos Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Doxorrubicina / Nanocápsulas / Neoplasias de la Mama Triple Negativas / Albúmina Sérica Humana / Docetaxel / Antineoplásicos Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article